VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $135,551 | -14.6% | 9,887 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $158,686 | +106.8% | 9,887 | 0.0% | 0.01% | +75.0% |
| Q1 2023 | $76,723 | +40069.1% | 9,887 | 0.0% | 0.00% | -55.6% |
| Q4 2022 | $191 | -99.9% | 9,887 | 0.0% | 0.01% | -10.0% |
| Q3 2022 | $211,000 | +56.3% | 9,887 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $135,000 | -41.8% | 9,887 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $232,000 | -12.1% | 9,887 | 0.0% | 0.01% | -11.1% |
| Q4 2021 | $264,000 | – | 9,887 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |